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Determinants of Prenatal Care and Supplement Use: The Case of Honduras 
 
ABSTRACT 
 
Context:  Literature suggests that prenatal care and prenatal supplement use improves pregnancy 
outcomes.  However, we do not know the factors associated with prenatal care and supplement 
use in Honduras. 
 
Objective:  To identify characteristics of Honduran women who are the least and most likely to 
use prenatal care and supplements. 
 
Methods:  Data from a 2001 Honduras cross-sectional survey of women was used to assess their 
use of prenatal care and supplements.  All data was weighted, resulting in a sample size of n = 
5647 women who had a live birth since January 1996.  Bivariate and multivariate analyses were 
used to examine factors associated with prenatal care and supplement use. 
 
Results:  Current education level was highly positively related to prenatal care and supplement 
use.  Women who were 35 years or older at the time of their most recent birth, currently 
unmarried, of non-Catholic religious affiliation, and of low SES were significantly less likely to 
have used prenatal care and supplements.  Women who reported the intentionality of their most 
recent birth as unwanted also were significantly less likely to have used prenatal care and 
supplements.  Prenatal care was the most significant determinant of prenatal supplement use. 
 
Conclusion:  There are significant differences between Honduran women who use prenatal care 
and supplements and women who do not.  Efforts to increase prenatal health services among 
underserved women, especially women who are older, unmarried, with no formal education, of 
low SES, of a non-Catholic religious affiliation, and at risk for an unwanted pregnancy, may 
significantly improve pregnancy outcomes in Honduras. 
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INTRODUCTION 
In developing countries, child and mother health is far behind that of industrialized 
countries.1,2,3,4  The significant disparities in child and maternal health indicators, in particular 
infant and maternal mortality, between developed and developing countries are greatly attributed 
to prenatal health service utilization and behaviors such as prenatal and obstetrical care and 
prenatal supplement use.1,2,3,4,5,6,7,8,9,10,11,12 
Prenatal care has played an important role in the reduction of infant mortality and 
morbidity.4,6,7  In countries with the lowest infant mortality rates, prenatal care is readily 
available.6  Lack of prenatal care has been shown to be a major risk factor for poor pregnancy 
outcomes.6  Studies have found increased utilization of prenatal care to be associated with a 
lower incidence of low birth weight, increased gestational age, lower infant mortality, and lower 
rates of preterm delivery.7,8,13,14,15,16  In U.S. studies, prenatal care has also been found to be the 
most cost-effective means for preventing low birth weight.17,18  A study in nearby Brazil found 
that each 10 percent increase in up-to-date prenatal care would result in 6.6 fewer infant deaths 
per 1,000 live births.7  Infants from women who attended no prenatal care visits are at a two-fold 
higher risk (range: 2.04-2.29) of being low birth weight as compared to infants of women who 
had received at least some prenatal care.7  A study in Chile discovered that women with good 
prenatal care had approximately one-third the rate of preterm deliveries and one-half the rate of 
perinatal mortality compared to that of women with poor or no prenatal care.8  Low birth weight 
infants who were born to women with prenatal care appear to have fewer neonatal intensive care 
days, shorter hospitalizations, better survival rates and fewer morbidities such as respiratory 
illness.15 
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Literature does not suggest that prenatal care significantly reduces maternal mortality.2  
Women who receive early prenatal care may be more likely to receive quality perinatal care 
compared to those who start prenatal care later in their pregnancies or not at all.17  Prenatal care 
may strive for early detection of obstetrical complications or high-risk pregnancies and, 
therefore, initiate prevention or intervention.16  However, Maine argues that literature does not 
support the approach that maternal mortality can be prevented through prenatal care programs in 
which obstetrical complications can be detected, predicted, or treated early, claiming that most 
obstetrical complications cannot be prevented or predicted.2  Maternal mortality appears to be 
mostly improved by essential obstetric care services, specifically for emergency obstetrical 
complications.1,2 
Prenatal supplement use has also been associated with improved pregnancy outcomes.  
Folic-acid containing supplements have been shown to reduce the risk of occurrent and recurrent 
neural tube defects by respective 60 and 70 percents, as well as other major, non-genetic 
syndromatic congenital abnormalities, urinary tract anomalies, cardiovascular defects, and 
orofacial clefts.19,20,21,22  Folate in combination with iron has shown positive effects on 
gestational weight gain and duration of pregnancy.22  Low folate and zinc intakes and circulating 
concentrations have been related to increased risks of preterm delivery and infant low birth 
weight.21,22 
Iron deficiency anemia, highly prevalent in developing countries, appears to increase the 
risk of preterm delivery and low calcium intake increases the risk of preeclampsia.22  In a study 
of multivitamin and mineral prenatal supplement use, women who started supplement use in the 
first trimester were found to have had a two-fold reduction in risk of preterm delivery and four-
fold reduction in risk of very preterm delivery.22  Their risk of low birth weight and very low 
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birth weight decreased by two-fold and six-fold, respectively.22  Even for women who did not 
begin multivitamin and mineral prenatal supplement use until the second trimester, their risk for 
preterm and very preterm delivery decreased by two-fold.22  Their risk of low birth weight and 
very low birth weight decreased by approximately two-fold and seven-fold.22  Other studies on 
the effects of multivitamin and mineral supplements have demonstrated similar reductions in 
preterm delivery and low birth weight.23 
With approximately 58 percent of women in developing countries suffering from anemia, 
mothers may also benefit from prenatal iron supplementation through an alleviation of anemic 
symptoms.3  They may experience improved physical well-being, less fatigue, improved 
appetite, and an appreciation for the benefits to the fetus.3 
Studies on the effects of micronutrients are difficult in that pregnant women in 
developing countries may experience multiple micronutrient deficiencies, making it difficult to 
assess the true benefits of a single micronutrient when deficiencies are still present.12  Even when 
supplementing with multiple micronutrients, a diet that remains inadequate in calories and 
protein would be limiting and it would be difficult to pinpoint the benefits that follow from each 
micronutrient.12 
While studies have shown that prenatal care and supplement use can have significant 
positive pregnancy outcomes, especially on birth outcomes, many women in developing 
countries do not have access to or are not utilizing prenatal care and supplements.3,9,10,11,12,16  
Therefore, it is important to determine the characteristics that influence use versus non-use of 
prenatal care and supplement use.  Research in developing countries has found many factors to 
be associated with prenatal care utilization.  The woman’s education level has a positive and 
significant association on the use of prenatal care.8,10,11,24,25,26,27  A study by Faundes in Chilé 
  4 
 
found that of the women studied, 40 percent with little or no education had good prenatal care 
compared to 48% of women with 3-8 years of education and 53% with higher education.8  
Health insurance coverage, income, household wealth, and housing characteristics such as 
presence of electricity in the house appear to be positively associated with prenatal care 
use.10,25,26,28  Women whose husbands held blue-collar occupations were significantly less likely 
to use prenatal care while women with husbands in white-collar occupations were more likely to 
use prenatal care.10,28  Potter claims that poverty and lack of familiarity with Western culture are 
important barriers to modern maternal health services.26  Potter also found that persons speaking 
only an indigenous language were less likely to use prenatal care.26 
Being married and duration of the marriage are positively associated with prenatal care 
use.8,11  In his study, Faundes found that only 35% of single women had good prenatal care 
compared to 57% of married women.8  Increasing maternal age has been associated with use of 
prenatal care, however, being 30 years or older has been negatively associated with prenatal care 
use.11,29  Women living in rural areas appear to be less likely to use prenatal care than women 
residing in urban areas.10,11,16,24  One study conducted in Brazil demonstrated that 80% of women 
in urban areas had at least some prenatal care while more than 40% of women residing in rural 
areas had no prenatal care at all.24  Ethnicity and religious background are also associated with 
prenatal care use.10,27 
Research shows parity to be associated with prenatal care utilization, but the direction of 
the association varies.10,11,25  Celik et al. found that women pregnant with their first child were 
more likely to use prenatal care than women with two or more previous pregnancies.10  However, 
Abbas et al. found that women of low parity (1-3) and high parity (7+) were significantly less 
likely to use prenatal care compared to women with parity of 4-6 children.11  In the U.S., use of 
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family planning services and intentionality of the pregnancy also have been found to be factors 
associated with prenatal care utilization such that women having unintended pregnancies attend 
prenatal care later or not at all.30,31,32 
There are some system factors that relate to prenatal care use as well.  Presence of well-
trained, well-equipped medical professionals is positively associated with prenatal care use.10  
Availability and accessibility of health services (i.e. existence of good roads, distance to services, 
and time and cost involved in traveling to services) are significantly associated with prenatal care 
use.10,26 
Studies in the U.S. have found increased primiparity, early nausea during pregnancy, 
earlier entry into care, increasing education level, increasing maternal age, and ethnicity (white) 
to be positively associated with prenatal supplement use.22,33  O’Scholl et al., found a high 
percentage of women using prenatal supplements, particularly women who began use in the first 
trimester, had had pregnancy complications such as early bleeding.22  Specific to folate 
supplements, O’Scholl reported the following negative associations: ethnicity (African-American 
and Hispanic), being unmarried, under 20 years of age, having less than a high school level 
education, multiparity, late entry into prenatal care, maternal confidence that her diet is good, an 
unstable home life, and side effects attributed to the supplement.21  She also reported that women 
with a history of adverse pregnancy outcomes were more likely to use supplements 
preconceptionally.21  However, research conducted in the United Kingdom found that 
supplementation during pregnancy was not affected by age, social class or reproductive history, 
but that it was influenced by advice that was received and whether or not the woman took iron 
supplements.34  The researchers found that prevalence of supplementation use among women 
who had received advice about vitamins during their pregnancy was almost three times as high 
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compared to women who had not received advice.34  The prevalence of supplementation use was 
highest among women who had received a specific recommendation for use and lowest among 
women who had been advised against it.34 
One study found that women with unwanted pregnancies were less likely to report 
preconceptional and prenatal daily vitamin use and less likely to increase daily vitamin use 
during pregnancy than women with intended pregnancies.31  Wulff et al. found that Swedish 
women’s use of iron-containing supplements during pregnancy was influenced by side effects of 
supplements, perceived need, and advice from midwives.35 
Determinants of prenatal supplement use in the U.S., U.K. and other industrialized 
countries may differ from that of developing countries.  Galloway et al. conducted a study on 
iron deficiency anemia and supplementation and women’s perceptions in eight developing 
countries including Honduras.3  The research shows that experiencing negative side effects is one 
reason for non-compliance with iron supplements during pregnancy but not the major reason as 
only one-tenth of the women in iron supplementation trials quit use due to side effects.3  The 
results showed that other barriers to iron supplement use included difficult access to and poor 
utilization of prenatal care services, lack of knowledge and awareness of anemia and its 
consequences, beliefs against consuming medications during pregnancy, and fears that taking too 
much iron may cause too much blood and increase birth weight, thereby making the delivery 
more difficult.3  Health system factors negatively associated with iron supplement use include 
poor access to supplies (i.e. poor utilization of prenatal care or inadequate supplies), poor quality 
of the tablets, inadequate counseling by and training of health providers, poor distribution 
systems, and ineffective communication materials.3,12 
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PURPOSE 
To date, we do not know specific factors associated with prenatal care and prenatal 
supplement use in Honduras.  It is important to examine both outcome variables because a 
woman may attend prenatal care, but not use prenatal supplements or vice versa.  Knowing the 
determinants of prenatal care and prenatal supplement utilization are important in designing 
public health interventions to target the underserved populations.  This study will examine the 
differences in characteristics between Honduran women who used prenatal care and prenatal 
supplements in their last pregnancy and Honduran women who did not.  This research also aims 
to explore the relationship between intentionality of the pregnancy and prenatal care and 
supplement use.  Through this analysis, we seek to identify the characteristics of women least 
likely to use prenatal care and prenatal supplements and recommend interventions to increase use 
of these services. 
METHODS 
Study Setting 
 
Honduras, a country located in Central America, has a population of approximately 6.7 
million.5,36  In the United Nations Human Development Index, Honduras is ranked at the lower 
end of the medium human development category: 115th out of 175 countries.37  The country’s 
literacy rate is 75.7 with no disparities between males and females.5  The total fertility rate is 4.3 
among women ages 15-49.36  According to Population Reference Bureau’s 2003 country profile, 
Honduras has an infant mortality rate of 37.1 per 1000 live births and a maternal mortality rate of 
220, although another source reports 108, per 100,000 live births.5,36  In comparison, the United 
States, ranked 7th, has an MMR of 9.8 per 100,000 live births and an IMR of 6.9 per 1,000 live 
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births in 2000.37,38  Honduras has a 9.1% prevalence of low birth weight and a high prevalence of 
neural tube defects (2.6 per 1,000 live births).5,39 
Study Design and Data Collection 
The target population was Honduran women of childbearing age who had ever been or 
were currently pregnant.  This study uses existing data from the 2001 Epidemiology and Family 
Health National Survey (ENESF-2001) of women.  The Honduran Association of Family 
Planning (ASHONLAFA), in conjunction with the CDC, conducted the cross-sectional survey 
using a multi-stage sampling design.  400 primary sampling units (PSU), each representing 
census segments, were selected for the survey.  The PSU’s probability of selection was 
proportional to the size of the population of the PSU.  Within each PSU, each household had the 
same probability of selection and thirty households were selected.  Female interviewers collected 
survey data in one-on-one interviews of Honduran women ages 15-49.  In total, data were 
collected on n = 8362 Honduran women ages 15-49. 
Data Measures 
 
Among women who had their last child born alive since January 1996, the outcome 
variable, prenatal care, was measured by the following questions: “Did you receive any prenatal 
care while pregnant with [name of last child born alive],” “In total, how many prenatal care visits 
did you have,” “During which month of your pregnancy did you have your first prenatal care 
visit?”  We categorized the number of prenatal care visits into groups of 1-4, 5-8, and 9+ visits.  
We determined the trimester in which prenatal care was initiated by classifying women who 
reported their first visit in the first to third month into a first trimester group, women who 
reported their first visit in the fourth to sixth month into a second trimester group, and women 
who reported their first visit in the seventh to ninth month into a third trimester group. 
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Among women who had a baby born alive since 1999, prenatal supplement use was 
determined by the following questions asked about each supplement: “During the pregnancy of 
[name of last child born alive] did you take: a) prenatal vitamins, b) iron tablets, and/or c) folic 
acid tablets,” “How many months pregnant were you when you started taking them [prenatal 
vitamins, iron, or folic acid],” and “For how many months did you take them [prenatal vitamins, 
iron, or folic acid] during the pregnancy?”  The trimester in which use was initiated was 
classified the same way as prenatal care.  The number of months of the respective supplement 
use was classified into 1-3, 4-6, and 7-9 months categories.  For ease of statistical analysis, we 
created an “Any Supplement Use” variable to account for use of any of the prenatal supplements 
(prenatal vitamins, iron tablets, and/or folic acid tablets). 
Independent variables that were examined include current age (15-19, 20-24, 25-29, 30-
34, 35-39, 40+); age at the time of the last live birth (< 20, 20-24, 25-29, 30-34, 35+); current 
marital status (married, living with a partner, formerly married [divorced, separated, widowed], 
single); religious affiliation (Catholic, Evangelical/Protestant, none/other); area of residence 
(urban or rural); current education level (none, incompleted primary education, completed 
primary education, incompleted secondary education, completed secondary education or higher); 
current socioeconomic status (SES) (low, medium, high); total number of children born alive; 
and time, in years, since the last live birth (<1, 1-2, 3-5).  Socioeconomic status was assessed 
through a goods and services index based on presence of nine household characteristics: piped 
water, toilet, electricity, radio, television, refrigerator, telephone, private vehicle, and electric or 
gas stove.  Intentionality of the last birth (intended, mistimed, unwanted) was also included in 
analyses and measured by asking “When you got pregnant with [name of last child born alive] 
did you want to become pregnant then, wanted to wait, or not want to have anymore children.” 
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Data Analysis 
 
For the purposes of this study, we excluded women who had never been pregnant, 
decreasing unweighted sample size to n = 6807.  Based on the nature of the prenatal care and 
supplement use measures, we only included women who had their last live birth since January 
1996 (n = 4486). Due to oversampling of some areas of Honduras, it was necessary to weight the 
data to make the observations more representative of the Honduras female population.  The 
weighted number of observations is n = 5647.  All analyses were weighted.  Although the data 
were collected using a clustered survey design, we did not correct for the clustered nature of the 
data.  All data were analyzed using SPSS.  We conducted univariate and bivariate analyses.  In 
the bivariate analyses, we used Pearson chi-square analysis to determine any significant 
differences among the women’s characteristics.  We also conducted multivariate logistic 
regression analyses to examine factors associated with prenatal care use and supplement use.  All 
adjusted results are reported as odds ratios.  P ≤ 0.05 was used to determine statistical 
significance. 
RESULTS 
 Table 1 describes characteristics of the women aged 15-49 who had a live birth since 
January 1996 from the 2001 Honduras sample.  The majority of the women in this sample were 
29 or younger, married or in consensual union, and Catholic.  More of these women lived in a 
rural area (56.9%) rather than an urban area (43.1%).  Seventy-seven percent of the women did 
not have higher than a primary education level.  Most of them were of a low or middle 
socioeconomic status.  Approximately 25% of the women were reporting on a last birth that was 
their fifth or higher order live birth.  Almost half of the last births were reported as intended, 
23% as mistimed, and the remaining 29% were unwanted. 
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Table 2 shows the overall distribution of prenatal care use, prenatal vitamin use, and any 
supplement use among the women who had a birth since 1996 (1999 for supplement use).  
Eighty-five percent of the women reported prenatal care use during the pregnancy of their last 
child born alive.  Of those who reported prenatal care use, 67.4% had their first prenatal care 
visit during the first trimester, 27.2% during the second trimester, and 4.9% during the third 
trimester.  The majority of prenatal care users (58.4%) reported 5-8 visits, 27.4% reported 1-4 
visits, and 13.2% reported 9+ visits. 
 Prenatal vitamin, iron tablet, and folic acid use was only assessed among women who had 
their last live birth since 1999.  Of all ever pregnant women since 1996 (n = 5647) there were n = 
1848 women who had their last live birth prior to 1999 and, therefore, were not asked the 
question on prenatal supplement use.   In total, the number of women with births since 1999 was 
n = 3799.  Of those, 66.6% used prenatal vitamins during the pregnancy of their last live birth.  
Among prenatal vitamin users, 58.8% initiated use in the first trimester, 25.1% in the second 
trimester, and 5.4% in the third trimester.  Although use tended to be initiated early, only 29.3% 
used prenatal vitamins for 7-9 months, while 23.2% and 46.3% used for 1-3 and 4-6 months, 
respectively.  Prevalence of any prenatal supplement use, defined as use of at least one prenatal 
supplement (prenatal vitamins, iron tablets, and/or folic acid tablets), was 74.9%.  Because the 
prevalence rates of prenatal vitamin use and any prenatal supplement use were similar, any 
prenatal supplement use was used in the Pearson chi-square and multivariate logistic regression 
analyses. 
Table 3 presents the distribution and significance of prenatal care utilization by the 
sampled women’s characteristics.  Significance tests found all the demographic characteristics to 
be associated with prenatal care in the expected directions.  All significance tests were p ≤ 0.001 
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except for years since last birth (p ≤ 0.01).  Use of prenatal care declined with increasing 
maternal age at birth.  Women who were currently married or in consensual union were 
significantly more likely to use prenatal care during the pregnancy of their last live birth than 
women who were formerly married or single.  Women with more education were more likely to 
have used prenatal care.  Ninety-eight percent of those with a secondary or higher education 
level reported attending prenatal care while only 66.3% of those with no education reported 
attending prenatal care.  Those with Catholic and Evangelical/Protestant religious affiliations 
reported less use of prenatal care than those with none/other religion.  Women who lived in an 
urban area were more likely to use prenatal care (88.3%) than those who lived in a rural area 
(82.5%).  As socioeconomic status increased so did the use of prenatal care: 80.8% for low SES, 
84.9% for middle SES, and 94.3% for high SES. 
Prenatal care appears to be associated with lower parity with 91.9% of women reporting 
about their first birth using prenatal care, 87.1% of women reporting about their second birth 
using prenatal care, 87.2% of women reporting about their third birth, 83.5% of women reporting 
about their fourth birth, and only 75.4% of women reporting about their fifth or higher live birth 
reporting use.  Women whose last live birth was prior to 1999 were less likely to report prenatal 
care use (83.2%) than those whose last live birth was since 1999 (86.1%).  Women who reported 
an intended or mistimed last birth reported similar rates of prenatal care use, 88.7% and 87.7% 
respectively, but among those who reported their last live birth as unwanted, only 77% used 
prenatal care. 
Table 4 shows two multivariate logistic regression models used to generate the adjusted 
odds ratios for prenatal care use among the sampled women.  Because of a high correlation 
(0.71) between age at last birth and total number of live births, Model 1 adjusts for all variables 
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except for total number of live births and Model 2 includes number of live births but not age at 
last birth.  In Model 1, women who were 35 or older at the time of the last birth were 
significantly less likely to have used prenatal care (OR 0.67 [0.52, 0.86]) than women age 25-29.  
Having the last live birth 3-5 years prior to the survey decreased the use of prenatal care by 0.74 
times (0.63, 0.87).  Compared to married women, single women were the least likely to have 
used prenatal care (OR 0.26 [0.18, 0.38]) followed by formerly married women (OR 0.44 [0.34, 
0.56]) and the women who were living in consensual union (OR 0.58 [0.47, 0.71]).   None/other 
religious affiliation was associated with a significant decrease in prenatal care use (OR 0.73 
[0.59, 0.91]). 
After adjusting for other variables, living in a rural area became insignificant.  However, 
we attribute this to the high correlations between area of residence, SES, and education level.  In 
Model 1, those with a high socioeconomic status were 1.68 times [1.20, 2.36] more likely to 
have used prenatal care than those of low SES.  We found middle SES to be insignificant.  
Current education level was one of the most significant determinants of prenatal care.  The 
pattern suggests that with increasing level of education, the likelihood of using prenatal care 
increased.  The biggest impact was for those with secondary education or higher (OR 12.37 
[6.68, 22.9]) compared with those with no education.  In a model that dropped education from 
the model, middle SES became significant in the expected direction, but area of residence 
remained insignificant (not shown).  Finally, women who had not wanted their last live birth 
were significantly less likely to have used prenatal care (OR 0.59 [0.50, 0.71]) compared to those 
with an intended birth. 
In Model 2, age at last birth was not included but total number of live births was. 
Compared to women whose last live birth was their first, increasing number of live births was 
  14 
 
associated with decreased use of prenatal care: two (OR 0.53[0.41, 0.70]), three (OR 0.59 [0.44, 
0.80]), four (OR 0.54 [0.39, 0.74]), and five or more (OR 0.38 [0.29, 0.51]).  The direction, 
magnitude and significance of the other variables were similar to that of Model 1.  When age at 
last birth and total number of live births were analyzed together (not shown), age at last birth 
became insignificant. 
Table 5 shows the distribution of any prenatal supplement use by the sampled women’s 
characteristics.  Pearson chi-square analysis found all variables to be significant determinants of 
prenatal supplement use.  All significance tests were p ≤ 0.001 except for years since last birth (p 
≤ 0.05).  Prenatal supplement use peaked among the 25-29 age group while the 19 or younger 
and the 35+ groups reported the lowest usage.  Marital status also affected prenatal supplement 
use.  Married women were the most likely to have used prenatal supplements (87.6%) followed 
by women in consensual union (80.2%), single women (75%), and formerly married women 
(73.7%).  Catholics were more likely to have used prenatal supplements than women of 
Evangelical/Protestant and none/other religious affiliations. 
Only 78.9% of women living in rural areas reported prenatal supplement use compared to 
85.2% of those residing in urban areas.  Education was directly correlated with prenatal 
supplement use with only 64.2% of those with no education reporting prenatal supplement use 
compared to 96.5% of those with a secondary or higher education level.  SES status was 
positively correlated with prenatal supplement use: 76.6% of low SES, 82.9% of middle SES, 
and 91.5% of high SES women.  Rates of prenatal supplement use were similar among women 
with one and two live births (86.8% and 85.9%) and with three and four live births (80.0% and 
80.7%); however, only 72.3% of women with five or more live births used prenatal supplements.  
Women who had their last live birth more recently (less than one year) were more likely to have 
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used prenatal supplements than women whose last live birth was more than one year prior to the 
survey.  There was little difference in prenatal supplement use between women who reported 
their last live birth as intended or as mistimed (84.6% and 84.3%), but women who reported an 
unwanted last live birth were less likely to have taken prenatal supplements (73.2%).  Suggesting 
a strong relationship between attending prenatal care and prenatal supplement use, 92.3% of 
those who attended prenatal care reported prenatal supplement use compared to only 12.8% of 
those who did not attend prenatal care. 
 Table 6 shows the adjusted odds ratios for prenatal supplement use.  As above, two 
models are used to reduce problems of multicollinearity due to a high correlation between age at 
last birth and number of live births.  In Model 1, the women who were under 20 at last birth and 
the women who were 35 or older at last birth were significantly less likely to use prenatal 
supplements with ORs of 0.75 [0.56, 1.00] and 0.69 [0.50, 0.94] than women age 25-29 at last 
birth.  After adjustment, one or more years since the last birth was no longer significant.  Having 
Evangelical/Protestant and none/other religious affiliations were negatively associated with 
prenatal supplement use.  Marital status appears to be a significant factor in prenatal supplement 
use.  Women who were in consensual union were 0.69 [0.55, 0.88] times less likely to use 
prenatal supplements compared to women who were married in Model 1.  Formerly married 
women were 0.43 [0.32, 0.59] times less likely to use prenatal supplements. Single women were 
the least likely to use prenatal supplements (OR 0.41 [0.27, 0.63]). 
 After adjustment for other factors, neither area nor SES was significant but current 
education level remained significant.  Prenatal supplement use increased with each education 
level: OR 1.67 [1.32, 2.13] for incompleted primary education, OR 3.03 [2.26, 4.06] for 
completed primary education, OR 3.84 [2.54, 5.80] for incompleted secondary education, and 
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OR 9.18 [4.51, 18.65] for completed secondary or higher education.  In a model that excluded 
education (not shown), both middle SES and high SES became significantly more likely to use 
prenatal supplements compared to those with low SES, but area of residence remained 
insignificant.  Women with an unwanted last live birth were significantly less likely (OR 0.61 
[0.49, 0.75]) to have used prenatal supplements than women with an intended or mistimed last 
live birth. 
 Except for age at last birth, which was not included in the model, we found that all of the 
variables that were significant in Model 1 were also significant in Model 2.  Model 2 examined 
the significance of total number of live births.  We found that women having three or five or 
more live births were significantly less likely to use prenatal supplements with ORs of 0.68 
[0.50, 0.92] and 0.59 [0.43, 0.80] compared to women reporting about their first birth.  The effect 
for women with four live births was not significant, possibly a consequence of a small sample 
size in this category.   
Because of the significant role of attending prenatal care on determining prenatal 
supplement use (model not shown), the determinants of these two outcomes are highly 
correlated.  Therefore to better understand determinants of prenatal supplement use, we ran 
logistic regression analyses for only women who attended prenatal care.  This provides a 
perspective on who used prenatal supplements and who did not among women who attended 
prenatal care. 
Table 7 presents the adjusted odds ratios for prenatal supplement use among prenatal care 
users.  Again, we used two models to account for the correlation between age at last birth and 
total number of live births.  We found some differences in the results of this analysis compared 
to Table 6.  In Model 1, being in consensual union and single marital status, 
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Evangelical/Protestant religion, and number of live births became insignificant.  Being younger 
than 20 at the last birth became even more negatively associated with prenatal supplement use 
(OR 0.50 [0.32, 0.78]).  Notably, older age at the time of last birth no longer was associated with 
prenatal supplement use, among users of prenatal care.  Of current marital status, only the 
formerly married category remained a significant determinant of prenatal supplement use (OR 
0.52 [0.33, 0.81]).  The none/other religious affiliation was still associated with being less likely 
to use prenatal supplements (OR 0.65 [0.45, 0.96]). 
All education levels remained positively correlated with prenatal supplement use; 
however, the odds ratios became smaller: incompleted primary education (OR 1.49 [1.01, 2.19]), 
completed primary education (OR 2.44 [1.54, 3.86], incompleted secondary education (OR 3.06 
[1.62, 5.81]), and completed secondary education or higher (OR 4.33 [1.82, 10.32]).  In the 
sample of prenatal care users, women with one or more years since their last birth were less 
likely to have used prenatal supplements (OR 0.62 [0.43, 0.90]) than women who’s last birth was 
in the last year.  Unwanted intentionality of the last live birth remained significantly associated 
with lower use of prenatal supplements.  Model 2 was similar to Model 1 with the exception of 
the Evangelical/Protestant group, which became significant (OR 0.73 [0.53, 0.99]). 
Table 8 describes the distribution of the use of prenatal supplements (prenatal vitamins, 
iron tablets, and folic acid) by the number of prenatal visits, and the trimester in which prenatal 
care was initiated.  Overall, among women who used prenatal care 82.5% used prenatal vitamins, 
51.7% took iron tablets, and 42.6% took folic acid.  The distribution shows that use of prenatal 
supplements increased with the number of prenatal care visits.  It also shows that women who 
initiated prenatal care early were more likely to use prenatal supplements. 
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Pearson chi-square analysis and post-hoc tests found significant differences in prenatal 
supplement use by number of prenatal visits and the trimester of initiation.   For prenatal 
vitamins, post-hoc tests showed significant differences between 1-4 visits and 5-8 or 9+ visits, 
but not between the 5-8 and 9+ visits’ women.  For iron tablets, the tests showed significant 
differences among all three groups.  For folic acid use, the significance was found between 1-4 
visits and 5-8 or 9+ visits.  This suggests that women who only attended prenatal care for four or 
fewer visits were less likely to use prenatal supplements compared to women who attended 5-8 
or 9+ visits.  However, only for iron tablet use was there significant difference between 5-8 visits 
and 9+ visits, but after five visits, there were no significant differences in prenatal vitamin or 
folic acid tablet use for women with more visits.  Although there were no significant differences 
in prenatal vitamin use between women who initiated care in the first or second trimesters, 
women who waited until the third trimester to initiate care were significantly less likely to have 
used them.  Women who began prenatal care in the first trimester were more likely to have used 
iron tablets and folic acid than all others; however, there were no significant differences in iron 
or folic acid use between those who initiated care in the second and third trimesters.  This 
suggests women who initiate prenatal care in the first trimester and attend for five or more visits 
have the most likelihood of using prenatal supplements compared to women who initiate later or 
have fewer visits. 
DISCUSSION 
This study found significant differences between the women in Honduras who utilized 
prenatal care and supplements and the women who did not.  In the multivariate analyses, women 
who were 35 years or older at the time of their last birth were the least likely to use prenatal care 
and supplements of all the age groups.  Women ages 35 years or older may have more children 
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for whom to care and less time to attend prenatal care or may feel more experienced with 
pregnancy and childbirth and therefore do not perceive a need for prenatal care or supplements.  
However, for women ages 35 or older who entered prenatal care, their age was no longer a 
significant determinant of prenatal supplement use.  While women who were 20 years or 
younger at the time of their most recent birth were not less likely to use prenatal care, they were 
less likely to use prenatal supplements.  This may be attributed to lack of knowledge or 
awareness of prenatal supplements and their importance or to having no history of any pregnancy 
complications or adverse outcomes. 
Greater time, in years, since the most recent live births was negatively associated with 
prenatal care and with prenatal supplement use specific to prenatal care users.  This may be due 
to recall bias in that women with more years since their last live birth may not recall their 
prenatal care and supplement use as well as women who have more recently given birth.  This 
association may also be attributed to improvements in the access to, distribution, awareness, and 
utilization of prenatal care services and supplements in the more recent period. 
Being in a consensual union, formerly married (widowed, separated, or divorced), or 
single, in order of significance, were negatively correlated with prenatal care and prenatal 
supplement use before excluding non-users of prenatal care, compared to married women.  
Women who are not married may have less family, social, and economic support than women 
who are married.  After excluding non-users of prenatal care, only women who were formerly 
married were significantly less likely to have used prenatal supplements.  This finding could be 
due to the decrease in sample size or the limitation that we could only account for current marital 
status which does not necessarily reflect the marital status at the time of the most recent birth.  
The fact that the woman is currently not married may reflect that at the time of the birth she had 
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less support from her partner.  If the woman was formerly married at the time of the most recent 
birth, she could have had less support in her life than married women or women in consensual 
union and could have had more emotional issues, socioeconomic problems, and children 
impacting her life than women who were single. 
Education appears to be one of the most significant determinants of prenatal care and 
supplement use.  Educated women may have greater knowledge of reproductive health and the 
importance of prenatal care and supplement use during pregnancy.  They may also have more 
family and social support and higher socioeconomic status.  High SES was positively associated 
with prenatal care, but was only associated with prenatal supplement use in one model.  Area 
was not significantly associated with prenatal care or prenatal supplement use.  Area and SES 
were not as highly associated with prenatal care as we had anticipated because of the correlation 
with education.  Education may account for the significant differences in use between rural and 
urban areas and between low, middle, and high SES.  SES and education did become more 
significant when we placed them in separate models (not shown). 
Religious affiliation also played a role in prenatal care and supplement use.  Women with 
no religion or a religious affiliation other than Catholic and Evangelical/Protestant were 
significantly less likely to have used prenatal care and prenatal supplements.  
Evangelical/Protestant religious affiliations were significantly less likely to use prenatal 
supplements in all but one model. 
Multiparous women were less likely to use prenatal care.  Women with parity of three or 
of five or more were less likely to have used prenatal supplement use before excluding non-users 
of prenatal care.  When we examined determinants of prenatal supplement use only among 
prenatal care users, parity became insignificant.  As age at last birth and parity were so highly 
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correlated, so are their plausible reasons for association.  Women with more children may have 
less time to attend prenatal care or adhere to prenatal supplement use.  They may also feel more 
experienced with pregnancy and childbirth and do not perceive the need for prenatal care or 
supplements.  That parity became insignificant when considering only prenatal care users 
suggests that multiparous women who did attend prenatal care were not any less likely to use 
prenatal supplements than other women whose last live birth was their first. 
Women who reported the intention of their most recent birth as unwanted were 
significantly less likely to use prenatal care and supplements across all models.  If a woman’s 
pregnancy is unwanted, she may not recognize her pregnancy as early as woman who wanted or 
just mistimed her pregnancy.  This may delay the initiation of prenatal care and supplement use.  
She may also be inexperienced or already have had all the children she wanted and therefore was 
unwilling to put the time and effort into proper prenatal care and supplement use. 
Although we did not include it in any of the models, we explored the association between 
history of negative pregnancy outcomes (any live births who died, stillbirths, and/or spontaneous 
abortions) and prenatal care and supplement use.  Having had at least one live birth who died 
was significantly associated with prenatal care and supplement use, but we were unable to 
determine the direction of the association due to the cross-sectional design of the survey and we 
could not determine which live birth had died. 
This study was not without several limitations. The Honduras survey was conducted in 
2001.  For prenatal care use, women who had had a live birth since January 1996 were 
questioned and for prenatal supplement use, women who had had a live birth since 1999 were 
questioned.  This could have introduced recall bias into the study, which may be seen in the 
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negative association between women who had had more years since their last live birth and 
prenatal care and supplement use. 
Another limitation is that we were unable to assess the marital status, educational status, 
SES level, and area of residence during the most recent pregnancy of the most recent birth.  We 
were only able to examine the current status of those variables.  The women’s marital status, 
educational level, SES, and area of residence may have been different at the time of the last birth 
than at the time of the survey.  However, because the associations were similar to what we 
expected and to findings in other studies, this limitation may not have significantly impacted the 
results. 
A third limitation was that the main factors associated with prenatal supplement use are 
the same as the factors associated with attendance at prenatal care.  To better understand the 
specific associations with using prenatal supplements, we performed the analysis of prenatal 
supplement use only among prenatal care users.  Prenatal supplement use analyses also had 
smaller sample sizes compared to that of prenatal care analyses because women who had their 
births prior to 1999 were not questioned. 
A final limitation is that we did not account for the cluster design of the survey, which 
may bias the results by ignoring intra-cluster correlations between observations from the same 
sampling units.  We decided that this was beyond the scope of the MPH research project, but we 
did account for the weighted nature of the data. 
CONCLUSION 
From this study, we can better understand which Honduran women are the least and most 
likely to use prenatal care and supplements.  Women who are older, unmarried, of a non-Catholic 
religious affiliation, with no formal education, low SES, and multiparous and whose pregnancy 
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is unwanted are the least likely to use prenatal care and supplements and therefore, should be the 
most targeted with interventions.  The most significant determinant of prenatal supplement use is 
prenatal care (model not shown).  Of those who attend prenatal care, women who initiate care 
sooner and for five or more visits are the most likely to use prenatal supplements.  Increasing the 
use of prenatal care among those least likely to use it should be the goal of an intervention.  If 
prenatal care utilization increases, prenatal supplement use likely will as well.  Indirect 
interventions may include increasing the education of women in Honduras, increasing the use of 
family planning to prevent unwanted and mistimed pregnancies, and improving health system 
factors such as the quality of and access to prenatal care and prenatal supplements.  Literature 
supports that prenatal care and supplement use can improve pregnancy outcomes.  Interventions 
to increase women’s use of prenatal care and supplement use among women who are least likely 
to use them may result in improved pregnancy outcomes and overall child and maternal health in 
Honduras.  
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Table 1. Characteristics of women ages 15 to 49 who had a live birth since Jan. 1996 in the 
Honduras 2001 sample 
 Total 
Variable N % 
Age   
   15-19 653 11.6 
   20-24 1501 26.6 
   25-29 1418 25.1 
   30-34 961 17.0 
   35-39 651 11.5 
   40+ 463 8.2 
Age at last birth   
   <20 1141 20.2 
   20-24 1630 28.9 
   25-29 1289 22.8 
   30-34 815 14.4 
   35+ 771 13.7 
Religion   
   Catholic 2908 51.5 
   Evang./Protestant 1885 33.4 
   None/Other 854 15.1 
Current marital status   
   Married 1765 31.3 
   Living w/partner 2795 49.5 
   Formerly married 819 14.5 
   Single 268 4.7 
Area   
   Urban 2435 43.1 
   Rural 3212 56.9 
Current education   
   None 673 11.9 
   Prim. Incomplete 2123 37.6 
   Prim. Complete 1573 27.9 
   Sec. Incomplete 737 13.1 
   Sec. Complete+ 541 9.6 
SES status   
   Low 2401 42.5 
   Middle 2112 37.4 
   High 1134 20.1 
Total live births   
   1 1437 25.4 
   2 1244 22.0 
   3 917 16.2 
   4 648 11.5 
   5+ 1401 24.8 
Years since last birth   
   < 1 855 15.2 
   1-2 2863 50.7 
   3-5 1904 33.7 
   Unknown 25 0.4 
Intentionality of last birth   
   Intended 2676 47.4 
   Mistimed 1311 23.2 
   Unwanted 1660 29.4 
Notes: All N’s are adjusted by the weighted design of the survey.  Unweighted N = 4486 for women ages 15-49 who had a live birth 
since January 1996.  Some total N’s are less than N = 5647 due to missing values. 
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Table 2. Use of prenatal care and prenatal supplements during the pregnancy of the last child 
born alive since January 1996 for prenatal care and since 1999 for prenatal supplements 
PRENATAL CARE 
Variable  
Prenatal care N = 5647  
   Yes 4802 85.0 
   No 845 15.0 
  
Initial prenatal care visit N = 4802  
   1st trimester 3237 67.4 
   2nd trimester 1308 27.2 
   3rd trimester 235 4.9 
   Unknown 22 0.5 
  
Prenatal visits 
N = 4802
 
   1-4 1316 27.4 
   5-8 2805 58.4 
   9+ 634 13.2 
   Unknown 47 1.0 
  
PRENATAL SUPPLEMENT USE 
   
Prenatal vitamin use 
N = 3799 
 
   Yes 2529 66.6 
   No 968 25.4 
   DN/DR 11 0.3 
   Unknown 291 7.7 
 
 
 
Initial prenatal vitamin use 
N = 2529
 
   1st trimester 1486 58.8 
   2nd trimester 888 25.1 
   3rd trimester 137 5.4 
   Unknown 18 0.7 
 
 
 
Duration of prenatal vitamin use 
N = 2529
 
   1-3 months 586 23.2 
   4-6 1171 46.3 
   7-9 742 29.3 
   Unknown 30 1.2 
 
 
 
Any supplement use 
N = 3799
 
   Yes 2846 74.9 
   No 653 17.2 
   Unknown 300 7.9 
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Note: Prenatal vitamin is defined as a prenatal multivitamin.  Any supplement use is defined as the mother used any or all of the 
following during the pregnancy: prenatal vitamins, iron tablets, and/or folic acid. All N’s are adjusted by the weighted design of the 
survey. 
 
 
 
 
 
 
 
 
 
Table 3. Distribution of prenatal care by women’s characteristics 
 
Received prenatal care (N = 4802) 
Variable % Χ2 
Age at last birth  *** 
   <20 87.6  
   20-24 86.5  
   25-29 87.4  
   30-34 82.8  
   35+ 76.5  
Years since last birth  ** 
   0-2 86.1  
   3-5 83.2  
Current marital status  *** 
   Married 90.9  
   Living w/partner 83.3  
   Formerly married 81.0  
   Single 77.2  
Religion  *** 
   Catholic 85.6  
   Evang./Protestant 86.2  
   None/Other 97.6  
Area  *** 
   Urban 88.3  
   Rural 82.5  
Current education  *** 
   None 66.3  
   Prim. Incomplete 82.1  
   Prim. Complete 89.5  
   Sec. Incomplete 92.0  
   Sec. Complete+ 97.6  
SES status  *** 
   Low 80.8  
   Middle 84.9  
   High 94.3  
Total live births  *** 
   1 91.9  
   2 87.1  
   3 87.2  
   4 83.5  
   5+ 75.4  
Intentionality of last birth  *** 
   Intended 88.7  
   Mistimed 87.7  
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   Unwanted 77.0  
Note: Proportions based on the row percentages of prenatal care users.  Significance tests are based on Pearson chi-square 
analysis. Significance: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, NS = Not Significant. 
 
 
 
 
 
 
 
 
 
 
Table 4. Adjusted odds ratios for prenatal care use 
 Adjusted ORs (95% CI) 
Variable Model 1 Model 2 
Age at last birth  N/A 
   <20 1.20 (0.92, 1.56)  
   20-24 0.96 (0.76, 1.21)  
   25-29 (ref) --  
   30-34 0.82 (0.63, 1.06)  
   35+ 0.67 (0.52, 0.86)  
Years since last birth   
   0-2 (ref) -- -- 
   3-5 0.74 (0.63, 0.87) 0.74 (0.63, 0.87) 
Current marital status   
   Married (ref) -- -- 
   Living w/partner 0.58 (0.47, 0.71) 0.57 (0.46, 0.70) 
   Formerly married 0.44 (0.34, 0.56) 0.40 (0.31, 0.51) 
   Single 0.26 (0.18, 0.38) 0.20 (0.13, 0.29) 
Religion   
   Catholic (ref) -- -- 
   Evang./Protestant 0.95 (0.79, 1.14) 0.96 (0.80, 1.15) 
   None/Other 0.73 (0.59, 0.91) 0.74 (0.60, 0.92) 
Area   
   Urban (ref) -- -- 
   Rural 1.01 (0.83, 1.24) 1.01 (0.83, 1.23) 
Current education   
   None (ref) -- -- 
   Prim. Incomplete 2.02 (1.65, 2.48) 1.97 (1.61, 2.42) 
   Prim. Complete 3.42 (2.66, 4.40) 3.19 (2.48, 4.11) 
   Sec. Incomplete 4.25 (2.99, 6.04) 3.86 (2.71, 5.50) 
   Sec. Complete+ 12.37 (6.68, 22.9) 10.59 (5.70, 19.7) 
SES status   
   Low (ref) -- -- 
   Middle 0.99 (0.81, 1.20) 0.96 (0.78, 1.17) 
   High 1.68 (1.20, 2.36) 1.54 (1.09, 217) 
Total live births N/A  
   1 (ref)  -- 
   2  0.53 (0.41, 0.70) 
   3  0.59 (0.44, 0.80) 
   4  0.54 (0.39, 0.74) 
   5+  0.38 (0.29, 0.51) 
Intentionality of last birth   
   Intended (ref) -- -- 
   Mistimed 0.82 (0.66, 1.01) 0.85 (0.69, 1.06) 
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   Unwanted 0.59 (0.50, 0.71) 0.69 (0.57, 0.83) 
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Table 5. Distribution of prenatal supplement use by women’s characteristics 
 Any Supplement Use (N = 2846) 
Variable % Χ2 
Age at last birth  *** 
   <20 79.4  
   20-24 83.1  
   25-29 84.9  
   30-34 80.3  
   35+ 79.6  
Years since last birth  * 
  < 1 83.7  
   1-3 80.6  
   4-5 N/A  
Current marital status  *** 
   Married 87.6  
   Living w/partner 80.2  
   Formerly married 73.7  
   Single 75.0  
Religion  *** 
   Catholic 83.3  
   Evang./Protestant 81.0  
   None/Other 75.4  
Area  *** 
   Urban 85.2  
   Rural 78.9  
Current education  *** 
   None 64.2  
   Prim. Incomplete 77.1  
   Prim. Complete 86.9  
   Sec. Incomplete 89.9  
   Sec. Complete+ 96.5  
SES status  *** 
   Low 76.6  
   Middle 82.9  
   High 91.5  
Total live births  *** 
   1 86.8  
   2 85.9  
   3 80.0  
   4 80.7  
   5+ 72.3  
Intentionality of last birth  *** 
   Intended 84.6  
   Mistimed 84.3  
   Unwanted 73.2  
Prenatal care  *** 
   Yes 92.3  
   No 12.8  
Note: Proportions based on the row percentages of prenatal care users.  Significance tests are based on Pearson chi-square 
analysis. Significance: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, NS = Not Significant. 
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Table 6. Adjusted odds ratios for prenatal supplement use 
 Adjusted ORs (95% CI) 
Variable Model 1 Model 2 
Age at last birth  N/A 
   <20 0.75 (0.56, 1.00)  
   20-24 0.87 (0.67, 1,14)  
   25-29 (ref) --  
   30-34 0.82 (0.60, 1.13)  
   35+ 0.69 (0.50, 0.94)  
Years since last birth   
   <1 (ref) -- -- 
   1-3 0.82 (0.66, 1.02) 0.82 (0.66, 1.02) 
Current marital status   
   Married (ref) -- -- 
   Living w/partner 0.69 (0.55, 0.88) 0.65 (0.51, 0.82) 
   Formerly married 0.43 (0.32, 0.59) 0.39 (0.29, 0.53) 
   Single 0.41 (0.27, 0.63) 0.32 (0.21, 0.50) 
Current education   
   None (ref) -- -- 
   Prim. Incomplete 1.67 (1.32, 2.13) 1.59 (1.25, 2.03) 
   Prim. Complete 3.03 (2.26, 4.06) 2.81 (2.10, 3.78) 
   Sec. Incomplete 3.84 (2.54, 5.80) 3.47 (2.29, 5.27) 
   Sec. Complete+ 9.18 (4.51, 18.65) 8.58 (4.21, 17.49) 
Religion   
   Catholic (ref) -- -- 
   Evang./Protestant 0.77 (0.63, 0.94) 0.76 (0.62, 0.94) 
   None/Other 0.69 (0.53, 0.88) 0.66 (0.51, 0.84) 
Area   
   Urban (ref) -- -- 
   Rural 1.03 (0.81, 1.29) 1.03 (0.82, 1.30) 
SES status   
   Low (ref) -- -- 
   Middle 1.12 (0.89, 1.41) 1.07 (0.85, 1.36) 
   High 1.53 (1.04, 2.25) 1.42 (0.97, 2.09) 
Total live births N/A  
   1 (ref)  -- 
   2  0.96 (0.71, 1.29) 
   3  0.68 (0.50, 0.92) 
   4  0.81 (0.57, 1.16) 
   5+  0.59 (0.43, 0.80) 
Intentionality of last birth   
   Intended (ref) -- -- 
   Mistimed 0.88 (0.70, 1.12) 0.88 (0.70, 1.12) 
   Unwanted 0.61 (0.49, 0.75) 0.72 (0.58, 0.90) 
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Table 7. Adjusted odds ratios for prenatal supplement use among prenatal care users 
 Adjusted ORs (95% CI) 
Variable Model 1 Model 2 
Age at last birth  N/A 
   <20 0.50 (0.32, 0.78)  
   20-24 0.82 (0.53, 1.26)  
   25-29 (ref) --  
   30-34 0.76 (0.46, 1.25)  
   35+ 0.66 (0.40, 1.09)  
Years since last birth   
   <1 (ref) -- -- 
   1-3 0.62 (0.43, 0.90) 0.63 (0.44, 0.90) 
Current marital status   
   Married (ref) -- -- 
   Living w/partner 0.82 (0.58, 1.17) 0.74 (0.52, 1.05) 
   Formerly married 0.52 (0.33, 0.81) 0.47 (0.30, 0.73) 
   Single 1.31 (0.57, 3.04) 1.09 (0.47, 2.56) 
Current education   
   None (ref) -- -- 
   Prim. Incomplete 1.49 (1.01, 2.19) 1.39 (0.95, 2.05) 
   Prim. Complete 2.44 (1.54, 3.86) 2.24 (1.41, 3.56) 
   Sec. Incomplete 3.06 (1.62, 5.81) 2.81 (1.47, 5.34) 
   Sec. Complete+ 4.33 (1.82, 10.32) 4.31 (1.81, 10.30) 
Religion   
   Catholic (ref) -- -- 
   Evang./Protestant 0.74 (0.54, 1.01) 0.73 (0.53, 0.99) 
   None/Other 0.65 (0.45, 0.96) 0.60 (0.41, 0.87) 
Area   
   Urban (ref) -- -- 
   Rural 1.10 (0.77, 1.56) 1.14 (0.80, 1.62) 
SES status   
   Low (ref) -- -- 
   Middle 1.09 (0.76, 1.57) 1.08 (0.75, 1.56) 
   High 1.10 (0.64, 1.92) 1.10 (0.63, 1.91) 
Total live births N/A  
   1 (ref)  -- 
   2  1.55 (0.97, 2.47) 
   3  0.82 (0.53, 1.27) 
   4  1.14 (0.70, 1.95) 
   5+  0.89 (0.56, 1.40) 
Intentionality of last birth   
   Intended (ref) -- -- 
   Mistimed 0.92 (0.64, 1.33) 0.89 (0.61, 1.28) 
   Unwanted 0.56 (0.40, 0.77) 0.63 (0.45, 0.89) 
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Table 8. Distribution of prenatal supplement use among those who attended prenatal care 
 
Prenatal Care Visits 
Trimester of Initiation Total 
Variable 1-4 5-8 9+ Χ2 1st 2nd 3rd Χ2  
 N = 943 N = 1738 N = 315  N = 1897 N = 931 N = 180  
N = 3020 
Prenatal vitamins    ***    *** 
 
   Yes 71.9 87.5 86.6  85.5 80.6 61.7  82.5 
   No 27.7 12.5 13.7  14.3 19.4 38.3  17.3 
   DN/DR 0.4 0 0  0.2 0 0  0.2 
         
 
Iron tablets    ***    *** 
 
   Yes 36.1 56.4 71.1  58.1 42.7 30.0  51.7 
   No 62.8 42.3 27.9  40.5 56.2 70.0  47.2 
   DN/DR 1.2 1.3 1.0  1.4 1.1 0  1.2 
          
Folic acid tablets    ***    ***  
   Yes 27.7 46.4 63.8  49.0 34.7 15.6  42.6 
   No 70.3 51.8 33.7  48.9 63.6 83.3  55.4 
   DK/DR 2.0 1.8 2.5  2.2 1.7 1.1  2.0 
Note: Proportions based on the column percentages among prenatal care users.  The N’s for prenatal care visits and trimester of 
initiation N’s are fewer than the total due to missing values among prenatal care users. 
 
